Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pleural Effusion I: Introduction

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Pleural Effusion II: Symptoms and Management

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Heart Failure V: Medical Management

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

Heart Failure III: Clinical Manifestations

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy of Surgeon-Administered Regional Anesthesia in Cardiac Surgery: A Double-Blinded, 2-Center, Randomized, Placebo-Controlled Trial.

Journal of cardiothoracic and vascular anesthesia·2026

Same author

Thoracoscopic Sympathectomy in Treatment-Resistant Essential Hypertension: A Novel Approach to Reduce Sympathetic Activity and Blood Pressure.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2026

Same author

Renal doppler ultrasound: comparison of measurements sampled in different anatomical locations.

Journal of clinical monitoring and computing·2026

Same author

Intraoperative Hypotension and Vasoactive Treatment: An International Survey of Anaesthesiologists.

Acta anaesthesiologica Scandinavica·2026

Same author

The physiological mirage: Why oxygen pulse overstates surgical success in pectus excavatum.

Journal of pediatric surgery·2026

Same author

Preoperative Right Ventricle-to-Pulmonary Artery Coupling Correlates With Intensive Care Length of Stay After Pulmonary Endarterectomy.

Journal of cardiothoracic and vascular anesthesia·2026

Same journal

Decoy receptor 3 as a diagnostic marker for sepsis: a meta-analysis.

Intensive care medicine experimental·2026

Same journal

Hidden effects of dobutamine on cardiac output.

Intensive care medicine experimental·2026

Same journal

Behaviour artificial intelligence technology to support the decision-making process of continuation or withdrawal of life-sustaining therapy.

Intensive care medicine experimental·2026

Same journal

Continuous intratracheal gas suctioning combined with ventilator leak-compensation may enhance carbon dioxide removal efficiency: a proof-of-concept study using a porcine model.

Intensive care medicine experimental·2026

Same journal

Timing-dependent renal protection of dapagliflozin in endotoxemic diabetic mice by real-time GFR and biomarkers.

Intensive care medicine experimental·2026

Same journal

Improving mortality prediction in critically ill cancer patients with a multidimensional machine learning model.

Intensive care medicine experimental·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 23, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

Fluid loading and norepinephrine infusion mask the left ventricular preload decrease induced by pleural effusion.

Kristian Borup Wemmelund^1,2, Viktor Kromann Ringgård^3,4, Simon Tilma Vistisen^4,5

¹Department of Anaesthesiology and Intensive Care, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N, Denmark. kristianwemmelund@gmail.com.

Intensive Care Medicine Experimental

|September 13, 2017

Summary

This summary is machine-generated.

Pleural effusion (PLE) reduces cardiac function, but fluid loading and norepinephrine normalize hemodynamics. The impact of PLE may be masked by these treatments.

Keywords:

Animal models Fluid therapy Norepinephrine Pleural effusion Thoracentesis Ventricular function

More Related Videos

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism

Published on: February 14, 2022

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

Related Experiment Videos

Last Updated: Feb 23, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism

Published on: February 14, 2022

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension

Published on: March 17, 2022

Area of Science:

Cardiovascular Physiology
Critical Care Medicine
Diagnostic Imaging

Background:

Pleural effusion (PLE) can cause hypotension and reduced cardiac output.
Fluid loading and vasopressors are common treatments for these conditions.
The study investigates the physiological effects of these treatments in the context of PLE.

Purpose of the Study:

To assess the impact of fluid loading and norepinephrine on cardiac function determinants in piglets with induced PLE.
To evaluate changes in left ventricular preload, contractility, and afterload using echocardiography and invasive measurements.

Main Methods:

A randomized, controlled laboratory study involving 30 piglets with induced bilateral PLE.
Interventions included fluid loading, incremental norepinephrine infusion, or control.
Hemodynamic parameters were measured using echocardiography and pressure-flow monitoring.

Main Results:

PLE decreased left ventricular end-diastolic area, mean arterial pressure, and cardiac output.
Fluid loading and norepinephrine (at specific doses) restored these parameters to baseline.
Norepinephrine increased contractility, while both treatments increased afterload. Inferior vena cava distensibility was unchanged.

Conclusions:

PLE significantly impairs left ventricular preload and global hemodynamics.
Fluid and norepinephrine effectively normalize hemodynamics but may mask the underlying PLE.
The hemodynamic significance of PLE might be underestimated during treatment.